Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis (Q46068912)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis |
scientific article |
Statements
1 reference
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis (English)
1 reference
Peter Libby
1 reference
Thomas F Lüscher
1 reference
M Elaine Husni
1 reference
Daniel H Solomon
1 reference
Henry Krum
1 reference
Frank Ruschitzka
1 reference
A Michael Lincoff
1 reference
Steven E Nissen
1 reference
Matthew C Becker
1 reference
Thomas H Wang
1 reference
Lisa Wisniewski
1 reference
Kathy Wolski
1 reference
Jeffrey S Borer
1 reference
Alice M Mascette
1 reference
David Y Graham
1 reference
Neville D Yeomans
1 reference
PRECISION Investigators
1 reference
25 February 2009
1 reference
157
1 reference
4
1 reference
606-612
1 reference
Identifiers
1 reference